Pfizer files patent infringement suit over Ibrance against Aurobindo, Dr. Reddy’s Pfizer is alleging that Aurobindo and Dr. Reddy's were planning separately to come out with generic versions of Ibrance before expiration of its patent. Ahold Delhaize, Centerbridge Partners acquire FreshDirectAhold Delhaize will hold a majority of FreshDirect’s shares, while Centerbridge Partners will be a minority equity investor with a 20% stake. Mars acquires Kind North America Mars announced its acquisition of Kind North America, which will be joining Kind International to become one organization, the company said. Editor's Note: New competitor, same solutions DSN editor in chief Seth Mendelson discusses the launch of Amazon pharmacy and what it means for the industry. Viatris launches following combination of Mylan, Upjohn With the combination of Mylan and Pfizer's Upjohn business complete, the new company, Viatris, has launched. Lupin, Concord earn FDA nod for generic Prograf Tacrolimus capsules had a market value of roughly $303 million, according to IQVIA September 2020 data. Breckenridge gets FDA blessing for generic Pomalyst Pomalyst had a market value of $957 million during the 12 months ended September 2020. CVS Health appoints Daniel Finke to lead Health Care Benefits division Dan Finke will lead the CVS Health Care Benefits segment, succeeding Karen Lynch, who will become president and CEO in February. AmerisourceBergen names chief diversity, inclusion officer Lonie Haynes is joining AmerisourceBergen as its new senior vice president and chief diversity and inclusion officer. Aurobindo Pharma completes MViyeS Pharma Ventures acquisition With the completion of the deal, Eugia Pharma Specialities and MViyeS Pharma Ventures have become subsidiaries of Aurobindo. First Previous 98 99 100 101 102 Next Last
